131 related articles for article (PubMed ID: 26356810)
1. Pokemon siRNA Delivery Mediated by RGD-Modified HBV Core Protein Suppressed the Growth of Hepatocellular Carcinoma.
Kong J; Liu X; Jia J; Wu J; Wu N; Chen J; Fang F
Hum Gene Ther Methods; 2015 Oct; 26(5):175-80. PubMed ID: 26356810
[TBL] [Abstract][Full Text] [Related]
2. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Pokemon protein expression inhibits hepatocellular carcinoma cell proliferation by suppression of AKT activity.
Zhu X; Dai Y; Chen Z; Xie J; Zeng W; Lin Y
Oncol Res; 2013; 20(8):377-81. PubMed ID: 23924858
[TBL] [Abstract][Full Text] [Related]
4. Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.
Guo Y; Wang J; Zhang L; Shen S; Guo R; Yang Y; Chen W; Wang Y; Chen G; Shuai X
Hepatology; 2016 Apr; 63(4):1240-55. PubMed ID: 26680504
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted inhibition by a novel strategy - mimoretrovirus expressing siRNA targeting the Pokemon gene.
Tian Z; Wang H; Jia Z; Shi J; Tang J; Mao L; Liu H; Deng Y; He Y; Ruan Z; Li J; Wu Y; Ni B
Curr Cancer Drug Targets; 2010 Dec; 10(8):932-41. PubMed ID: 20879980
[TBL] [Abstract][Full Text] [Related]
6. Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription.
Kong J; Liu X; Li X; Wu J; Wu N; Chen J; Fang F
Hepatol Int; 2016 May; 10(3):493-500. PubMed ID: 26797719
[TBL] [Abstract][Full Text] [Related]
7. Depletion of Pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras.
Zhang QL; Tian DA; Xu XJ
Onkologie; 2011; 34(10):526-31. PubMed ID: 21985851
[TBL] [Abstract][Full Text] [Related]
8. An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.
Wu C; Gong F; Pang P; Shen M; Zhu K; Cheng D; Liu Z; Shan H
PLoS One; 2013; 8(6):e66416. PubMed ID: 23922634
[TBL] [Abstract][Full Text] [Related]
9. miR-125/Pokemon auto-circuit contributes to the progression of hepatocellular carcinoma.
Kong J; Liu X; Li X; Wu J; Wu N; Chen J; Fang F
Tumour Biol; 2016 Jan; 37(1):511-9. PubMed ID: 26227218
[TBL] [Abstract][Full Text] [Related]
10. Pokemon and MEF2D co-operationally promote invasion of hepatocellular carcinoma.
Hong X; Hong XY; Li T; He CY
Tumour Biol; 2015 Dec; 36(12):9885-93. PubMed ID: 26164003
[TBL] [Abstract][Full Text] [Related]
11. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
12. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
13. Suppression of hepatitis B virus-derived human hepatocellular carcinoma by NF-kappaB-inducing kinase-specific siRNA using liver-targeting liposomes.
Cho HA; Park IS; Kim TW; Oh YK; Yang KS; Kim JS
Arch Pharm Res; 2009 Jul; 32(7):1077-86. PubMed ID: 19641890
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.
Kong J; Diao Z; Deng X; Zhong H; Yao W; Hu X
Oncol Rep; 2007 Jul; 18(1):279-85. PubMed ID: 17549380
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific RNA interference targeting Pokemon suppresses tumor growth and induces apoptosis in prostate cancer.
Li Y; Xu S; Wang X; Shi H; Sun Z; Yang Z
Urology; 2013 Feb; 81(2):467.e1-7. PubMed ID: 23374847
[TBL] [Abstract][Full Text] [Related]
16. microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation.
Jin XL; Sun QS; Liu F; Yang HW; Liu M; Liu HX; Xu W; Jiang YY
J Cell Biochem; 2013 Jul; 114(7):1625-33. PubMed ID: 23355454
[TBL] [Abstract][Full Text] [Related]
17. Pokemon reduces Bcl-2 expression through NF-κ Bp65: A possible mechanism of hepatocellular carcinoma.
Zhao X; Ning Q; Sun X; Tian D
Asian Pac J Trop Med; 2011 Jun; 4(6):492-7. PubMed ID: 21771706
[TBL] [Abstract][Full Text] [Related]
18. EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma.
Gao J; Yu Y; Zhang Y; Song J; Chen H; Li W; Qian W; Deng L; Kou G; Chen J; Guo Y
Biomaterials; 2012 Jan; 33(1):270-82. PubMed ID: 21963149
[TBL] [Abstract][Full Text] [Related]
19. Expression of the proto-oncogene Pokemon in colorectal cancer--inhibitory effects of an siRNA.
Zhao GT; Yang LJ; Li XX; Cui HL; Guo R
Asian Pac J Cancer Prev; 2013; 14(9):4999-5005. PubMed ID: 24175766
[TBL] [Abstract][Full Text] [Related]
20. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
